Funding for this research was provided by:
DFG ImmunoSensation (EXC 1023)
Text and Data Mining valid from 2020-02-10
Received: 14 November 2019
Accepted: 27 January 2020
First Online: 10 February 2020
Ethics approval and consent to participate
: Specimens and clinical data were acquired with informed consent and Human Ethics Review Committee approval of the University Hospital Bonn (Ethics Review Committee Protocol No. 187/16).
: Not applicable.
: F.H., D.N., and JL have received speakers’ honoraria or travel expense reimbursements from the following companies: Roche, BMS, Pierre Fabre, Novartis and MSD. All remaining authors declare no conflicts of interest.